Cumberland Pharmaceuticals Inc - Company Profile

Powered by

All the data and insights you need on Cumberland Pharmaceuticals Inc in one report.

$ $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Cumberland Pharmaceuticals Inc Strategy Report

  • Understand Cumberland Pharmaceuticals Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Cumberland Pharmaceuticals Inc: Overview

Select Item

Related keylists

Cumberland Pharmaceuticals Inc (Cumberland), is a specialty pharmaceutical company that acquires, develops, and commercializes branded prescription products. Its primary target markets are hospital acute care, gastroenterology, and cancer supportive care. The company offers branded prescription products under Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Hepatoren, Boxaban, Vasculan, Portaban, and RediTrex brand names. Cumberland Pharma promotes approved products through its hospital and gastroenterology sales forces in the US. The company is also establishing a network of international partners to commercialize its products in their countries. Cumberland Pharma is headquartered in Nashville, Tennessee, the US.

 Gain a 360-degree view of Cumberland Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of Cumberland Pharmaceuticals Inc and make more informed decisions for your business Find out more
Headquarters United States of America
Address 2525 W End Ave Ste 950, Nashville, Tennessee, 37203-1608
Website www.cumberlandpharma.com
Telephone 1 615 2550068
No of Employees 91
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange CPIX (NASD)
Revenue (2022) $39.6M -5.9% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ -12.7% (2022 vs 2021)
Market Cap* $23.1M
Net Profit Margin (2022) XYZ -19.8% (2022 vs 2021)
* As of and is in US$
View Cumberland Pharmaceuticals Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Cumberland Pharmaceuticals Inc premium industry data and analytics

60+

Clinical Trials

Determine Cumberland Pharmaceuticals Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Catalyst Calendar

Proactively evaluate Cumberland Pharmaceuticals Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

17+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Cumberland Pharmaceuticals Inc’s relevant decision makers and contact details.

10+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Cumberland Pharmaceuticals Inc and assess market opportunity for new entrants with patient population 8-year forecasts.

9

Marketed Drugs

Understand Cumberland Pharmaceuticals Inc’s commercialized product portfolio to stay one step ahead of the market.

7

Pipeline Drugs

Identify which of Cumberland Pharmaceuticals Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

6

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

3

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Cumberland Pharmaceuticals Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Marketed Acetadote
Acetadote - Acetaminophen Poisoning Caldolor
Caldolor - Pain and Fever Kristalose
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Cumberland Pharmaceuticals Inc portfolio and identify potential areas for collaboration Understand Cumberland Pharmaceuticals Inc portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Regulatory Approval In May, the company received approval from US Food and Drug Administration (FDA) for Caldolor for the treatment of fever and pain in infants.
2022 Contracts/Agreements In May, the company entered an agreement with Verity Pharmaceuticals International Ltd. for the expansion of the company's new Sancuso oncology support product.
2022 New Products/Services In March, the company in partnership with Tabuk Pharmaceutical Manufacturing Company and Astra Industrial Group, had launched the injection Vibativ in the Middle East area.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Cumberland Pharmaceuticals Inc Takeda Pharmaceutical Co Ltd Perrigo Co Plc Ironwood Pharmaceuticals Inc RVL Pharmaceuticals Plc
Headquarters United States of America Japan Ireland United States of America United States of America
City Nashville Chuo-Ku Dublin Boston Bridgewater
State/Province Tennessee Tokyo - Massachusetts New Jersey
No. of Employees 91 49,095 9,140 267 125
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
A.J. Kazimi Chief Executive Officer; Chairman Executive Board 1999 64
John Hamm Director - Finance and Accounting; Chief Financial Officer Senior Management 2021 65
James L. Herman Senior Vice President - National Accounts; Chief Compliance Officer Senior Management - 65
Todd Anthony Vice President- Organizational Development Senior Management - 62
Chris T. Bitterman Vice President - Sales and Marketing Senior Management - 58
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Cumberland Pharmaceuticals Inc key executives to enhance your sales strategy Gain insight into Cumberland Pharmaceuticals Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward